These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 29653065)

  • 1. TET2: A Novel Epigenetic Regulator and Potential Intervention Target for Atherosclerosis.
    Liu Y; Peng W; Qu K; Lin X; Zeng Z; Chen J; Wei D; Wang Z
    DNA Cell Biol; 2018 Jun; 37(6):517-523. PubMed ID: 29653065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tet methylcytosine dioxygenase 2 inhibits atherosclerosis via upregulation of autophagy in ApoE-/- mice.
    Peng J; Yang Q; Li AF; Li RQ; Wang Z; Liu LS; Ren Z; Zheng XL; Tang XQ; Li GH; Tang ZH; Jiang ZS; Wei DH
    Oncotarget; 2016 Nov; 7(47):76423-76436. PubMed ID: 27821816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Yin-Yang Dynamics of DNA Methylation Is the Key Regulator for Smooth Muscle Cell Phenotype Switch and Vascular Remodeling.
    Zhuang J; Luan P; Li H; Wang K; Zhang P; Xu Y; Peng W
    Arterioscler Thromb Vasc Biol; 2017 Jan; 37(1):84-97. PubMed ID: 27879253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA methylcytosine dioxygenase ten-eleven translocation 2 enhances lipopolysaccharide-induced cytokine expression in human dental pulp cells by regulating MyD88 hydroxymethylation.
    Wang X; Feng Z; Li Q; Yi B; Xu Q
    Cell Tissue Res; 2018 Aug; 373(2):477-485. PubMed ID: 29654353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ten-eleven translocation-2 (TET2) is a master regulator of smooth muscle cell plasticity.
    Liu R; Jin Y; Tang WH; Qin L; Zhang X; Tellides G; Hwa J; Yu J; Martin KA
    Circulation; 2013 Oct; 128(18):2047-57. PubMed ID: 24077167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coiled-coil domain-containing 80 accelerates atherosclerosis development through decreasing lipoprotein lipase expression via ERK1/2 phosphorylation and TET2 expression.
    Gong D; Zhang Q; Chen LY; Yu XH; Wang G; Zou J; Zheng XL; Zhang DW; Yin WD; Tang CK
    Eur J Pharmacol; 2019 Jan; 843():177-189. PubMed ID: 30439364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paeonol suppresses the effect of ox-LDL on mice vascular endothelial cells by regulating miR-338-3p/TET2 axis in atherosclerosis.
    Yu Y; Yan R; Chen X; Sun T; Yan J
    Mol Cell Biochem; 2020 Dec; 475(1-2):127-135. PubMed ID: 32770325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tet1 and Tet2 Protect DNA Methylation Canyons against Hypermethylation.
    Wiehle L; Raddatz G; Musch T; Dawlaty MM; Jaenisch R; Lyko F; Breiling A
    Mol Cell Biol; 2016 Feb; 36(3):452-61. PubMed ID: 26598602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The TET2 interactors and their links to hematological malignancies.
    Pan F; Weeks O; Yang FC; Xu M
    IUBMB Life; 2015 Jun; 67(6):438-45. PubMed ID: 26099018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The methylcytosine dioxygenase Tet2 promotes DNA demethylation and activation of cytokine gene expression in T cells.
    Ichiyama K; Chen T; Wang X; Yan X; Kim BS; Tanaka S; Ndiaye-Lobry D; Deng Y; Zou Y; Zheng P; Tian Q; Aifantis I; Wei L; Dong C
    Immunity; 2015 Apr; 42(4):613-26. PubMed ID: 25862091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TET family proteins and 5-hydroxymethylcytosine in esophageal squamous cell carcinoma.
    Murata A; Baba Y; Ishimoto T; Miyake K; Kosumi K; Harada K; Kurashige J; Iwagami S; Sakamoto Y; Miyamoto Y; Yoshida N; Yamamoto M; Oda S; Watanabe M; Nakao M; Baba H
    Oncotarget; 2015 Sep; 6(27):23372-82. PubMed ID: 26093090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tet2 is required to resolve inflammation by recruiting Hdac2 to specifically repress IL-6.
    Zhang Q; Zhao K; Shen Q; Han Y; Gu Y; Li X; Zhao D; Liu Y; Wang C; Zhang X; Su X; Liu J; Ge W; Levine RL; Li N; Cao X
    Nature; 2015 Sep; 525(7569):389-393. PubMed ID: 26287468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TET2 coactivates gene expression through demethylation of enhancers.
    Wang L; Ozark PA; Smith ER; Zhao Z; Marshall SA; Rendleman EJ; Piunti A; Ryan C; Whelan AL; Helmin KA; Morgan MA; Zou L; Singer BD; Shilatifard A
    Sci Adv; 2018 Nov; 4(11):eaau6986. PubMed ID: 30417100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic Function of TET Family, 5-Methylcytosine, and 5-Hydroxymethylcytosine in Hematologic Malignancies.
    Li W; Xu L
    Oncol Res Treat; 2019; 42(6):309-318. PubMed ID: 31055566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TET2 promotes IL-1β expression in J774.1 cell through TLR4/MAPK signaling pathway with demethylation of TAB2 promoter.
    Liang Y; Zeng J; Luo B; Li W; He Y; Zhao W; Hu N; Jiang N; Luo Y; Xian Y; Liu J; Zheng X
    Mol Immunol; 2020 Oct; 126():136-142. PubMed ID: 32823238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Roles of ten eleven translocation proteins family and 5-hydroxymethylcytosine in epigenetic regulation of stem cells and regenerative medicine].
    Zhao JF; Li D; An Y
    Beijing Da Xue Xue Bao Yi Xue Ban; 2021 Feb; 53(2):420-424. PubMed ID: 33879920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of high 5-hydroxymethylcytosine levels with Ten Eleven Translocation 2 overexpression and inflammation in Sjögren's syndrome patients.
    Lagos C; Carvajal P; Castro I; Jara D; González S; Aguilera S; Barrera MJ; Quest AFG; Bahamondes V; Molina C; Urzúa U; Hermoso MA; Leyton C; González MJ
    Clin Immunol; 2018 Nov; 196():85-96. PubMed ID: 29894742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TET2 as an epigenetic master regulator for normal and malignant hematopoiesis.
    Nakajima H; Kunimoto H
    Cancer Sci; 2014 Sep; 105(9):1093-9. PubMed ID: 25040794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel epigenetic marker, Ten-eleven translocation family member 2 (TET2), is identified in the intractable epileptic brain and regulates ATP binding cassette subfamily B member 1 (ABCB1) in the blood-brain barrier.
    Kong FC; Lang LQ; Hu J; Zhang XL; Zhong MK; Ma CL
    Bioengineered; 2022 Mar; 13(3):6638-6649. PubMed ID: 35235761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic silencing of TET2 and TET3 induces an EMT-like process in melanoma.
    Gong F; Guo Y; Niu Y; Jin J; Zhang X; Shi X; Zhang L; Li R; Chen L; Ma RZ
    Oncotarget; 2017 Jan; 8(1):315-328. PubMed ID: 27852070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.